Published online 3 July 2006 doi:10.1084/jem.20052203
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 7, 1637-1642
Role of HMGB1 in apoptosis-mediated sepsis lethality
Shixin Qin1,
Haichao Wang2,
Renqi Yuan4,
Hui Li4,
Mahendar Ochani4,
Kanta Ochani4,
Mauricio Rosas-Ballina4,
Chris J. Czura4,
Jared M. Huston4,
Ed Miller3,
Xinchun Lin3,
Barbara Sherry5,
Anjali Kumar1,
Greg LaRosa1,
Walter Newman1,
Kevin J. Tracey4,5, and
Huan Yang4,5
1 Critical Therapeutics, Inc., Lexington, MA 02421
2 Department of Emergency Medicine, 3 Department of Surgery, North Shore University Hospital, 4 Laboratory of Biomedical Science, and 5 Center for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, NY 11030
CORRESPONDENCE Huan Yang: hyang{at}nshs.edu
Severe sepsis, a lethal syndrome after infection or injury, is the third leading cause of mortality in the United States. The pathogenesis of severe sepsis is characterized by organ damage and accumulation of apoptotic lymphocytes in the spleen, thymus, and other organs. To examine the potential causal relationships of apoptosis to organ damage, we administered Z-VAD-FMK, a broad-spectrum caspase inhibitor, to mice with sepsis. We found that Z-VAD-FMKtreated septic mice had decreased levels of high mobility group box 1 (HMGB1), a critical cytokine mediator of organ damage in severe sepsis, and suppressed apoptosis in the spleen and thymus. In vitro, apoptotic cells activate macrophages to release HMGB1. Monoclonal antibodies against HMGB1 conferred protection against organ damage but did not prevent the accumulation of apoptotic cells in the spleen. Thus, our data indicate that HMGB1 production is downstream of apoptosis on the final common pathway to organ damage in severe sepsis.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Liu, G., Wang, J., Park, Y.-J., Tsuruta, Y., Lorne, E. F., Zhao, X., Abraham, E.
(2008). High Mobility Group Protein-1 Inhibits Phagocytosis of Apoptotic Neutrophils through Binding to Phosphatidylserine. J. Immunol.
181: 4240-4246
[Abstract]
[Full Text]
-
Huston, J. M., Wang, H., Ochani, M., Ochani, K., Rosas-Ballina, M., Gallowitsch-Puerta, M., Ashok, M., Yang, L., Tracey, K. J., Yang, H.
(2008). Splenectomy Protects against Sepsis Lethality and Reduces Serum HMGB1 Levels. J. Immunol.
181: 3535-3539
[Abstract]
[Full Text]
-
Alleva, L. M., Budd, A. C., Clark, I. A.
(2008). Systemic Release of High Mobility Group Box 1 Protein during Severe Murine Influenza. J. Immunol.
181: 1454-1459
[Abstract]
[Full Text]
-
Chorny, A., Anderson, P., Gonzalez-Rey, E., Delgado, M.
(2008). Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria. J. Immunol.
180: 8369-8377
[Abstract]
[Full Text]
-
Plitas, G., Burt, B. M., Nguyen, H. M., Bamboat, Z. M., DeMatteo, R. P.
(2008). Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med.
205: 1277-1283
[Abstract]
[Full Text]
-
Chorny, A., Delgado, M.
(2008). Neuropeptides Rescue Mice from Lethal Sepsis by Down-regulating Secretion of the Late-Acting Inflammatory Mediator High Mobility Group Box 1. Am. J. Pathol.
172: 1297-1307
[Abstract]
[Full Text]
-
Williams, J. H. H., Ireland, H. E.
(2008). Sensing danger--Hsp72 and HMGB1 as candidate signals. J. Leukoc. Biol.
83: 489-492
[Abstract]
[Full Text]
-
Barkauskaite, V., Ek, M., Popovic, K., Harris, H.E., Wahren-Herlenius, M., Nyberg, F.
(2007). Translocation of the novel cytokine HMGB1 to the cytoplasm and extracellular space coincides with the peak of clinical activity in experimentally UV-induced lesions of cutaneous lupus erythematosus. Lupus
16: 794-802
[Abstract]
-
Jiang, W., Bell, C. W., Pisetsky, D. S.
(2007). The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid. J. Immunol.
178: 6495-6503
[Abstract]
[Full Text]
-
Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., Lotze, M. T.
(2007). Masquerader: High Mobility Group Box-1 and Cancer. Clin. Cancer Res.
13: 2836-2848
[Abstract]
[Full Text]
-
Milbrandt, E. B., Ishizaka, A., Angus, D. C.
(2007). Update in Critical Care 2006. Am. J. Respir. Crit. Care Med.
175: 638-648
[Full Text]
-
Li, W., Li, J., Ashok, M., Wu, R., Chen, D., Yang, L., Yang, H., Tracey, K. J., Wang, P., Sama, A. E., Wang, H.
(2007). A Cardiovascular Drug Rescues Mice from Lethal Sepsis by Selectively Attenuating a Late-Acting Proinflammatory Mediator, High Mobility Group Box 1. J. Immunol.
178: 3856-3864
[Abstract]
[Full Text]
-
Bianchi, M. E.
(2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol.
81: 1-5
[Abstract]
[Full Text]
-
Ito, N., DeMarco, R. A., Mailliard, R. B., Han, J., Rabinowich, H., Kalinski, P., Stolz, D. B., Zeh, H. J. III, Lotze, M. T.
(2007). Cytolytic cells induce HMGB1 release from melanoma cell lines. J. Leukoc. Biol.
81: 75-83
[Abstract]
[Full Text]